[144] Cellebrite DI Ltd. SEC Filing

Rhea-AI Filing Summary

Form 144 notice shows a proposed sale of 25,390 common shares of Cellebrite DI Ltd. (CLBT) through Morgan Stanley Smith Barney LLC on the NASDAQ with an aggregate market value of $478,949.34. The filing reports 244,469,106 shares outstanding, so the proposed sale equals roughly 0.01% of the outstanding stock.

The securities listed were mainly acquired under the issuer’s registered plans: two lots of 4,829 shares each from option exercises on 10/06/2025 and 15,732 shares from restricted stock vesting on 02/14/2024. The filer also disclosed two recent sales by the same person in September 2025 totaling 40,044 shares for gross proceeds of $707,057.23. The signer certifies no undisclosed material adverse information.

Positive

• Shares were acquired under registered plans (option exercises and restricted stock vesting), indicating routine compensation liquidity
• Proposed sale is small relative to outstanding shares (~0.01% of the 244,469,106 shares outstanding)

Negative

• Filer executed recent sales in September 2025 totaling 40,044 shares for $707,057.23, showing ongoing dispositions
• Planned sale creates additional market supply of 25,390 shares on 10/06/2025 valued at $478,949.34

Insights

Equity Compensation Analyst

TL;DR: Routine post-vesting/option sales under Rule 144, small relative to float.

The sale arises from exercise of options and vesting of restricted stock under registered plans, with 25,390 shares proposed for sale on 10/06/2025. These are standard liquidity events when equity awards become transferable; the filing names a registered broker and cites Services Rendered as the payment nature for recent acquisitions.

Because the proposed block equals about 0.01% of the 244,469,106 shares outstanding, the direct market impact is likely limited. Monitor any additional scheduled disposals or trading-plan disclosures that could increase supply over the next weeks.

Corporate Governance Specialist

TL;DR: Disclosure is consistent with Rule 144 requirements and includes prior recent sales.

The notice includes the filer’s representation that no material nonpublic information exists and records two prior sales in September 2025 totaling 40,044 shares for $707,057.23. Those prior disposals suggest ongoing personal liquidity activity rather than a single large exit.

Key items to watch are any subsequent Form 144 filings or a 10b5-1 plan adoption date; absent those, these entries appear procedural and unlikely to change control or governance dynamics in the near term.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25390	478949.34	244469106	10/06/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/06/2025	Exercise of options under a registered plan	Issuer			4829	10/06/2025	Services Rendered
Common	10/06/2025	Exercise of options under a registered plan	Issuer			4829	10/06/2025	Services Rendered
Common	02/14/2024	Restricted stock vesting under a registered plan	Issuer			15732	02/14/2024	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DANA GERNER 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Common	09/19/2025	27166	481313.62
DANA GERNER 94 Shlomo Shmelzer Road Petah Tikva L3 4970602	Common	09/11/2025	12878	225743.61

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CLBT Form 144 filed for 10/06/2025 disclose?

It discloses a proposed sale of 25,390 common shares via Morgan Stanley Smith Barney LLC on the NASDAQ with aggregate value $478,949.34.

Who is the seller named in the CLBT Form 144?

The filing identifies Dana Gerner as the person selling the shares; the broker is Morgan Stanley Smith Barney LLC.

How were the shares being sold acquired?

The securities were acquired through option exercises on 10/06/2025 and restricted stock vesting on 02/14/2024, with payment described as Services Rendered.

Has this person sold related securities recently?

Yes. The filer reported sales on 09/11/2025 (12,878 shares, $225,743.61) and 09/19/2025 (27,166 shares, $481,313.62), totaling 40,044 shares.

How material is the proposed sale to CLBT’s share count?

The proposed 25,390 shares represent roughly 0.01% of the reported 244,469,106 shares outstanding, a very small relative amount.